Post Authorization Safety Study (PASS) to Investigate Relevant Safety Outcomes among Patients Treated with Benepali for Psoriasis within the British Association of Dermatologists Biologic Interventions Register (BADBIR)

First published 17/08/2026

Last updated 24/09/2026

EU PAS number:

EUPAS1000001086

Study

Finalised

Download as PDF

Documents

Study protocol

No information provided.

Study results

No information provided.

Study report

SB4_BADBIR_Final Study Report_Final.pdf

English (710.32 KB - PDF) View document

ENCePP Seal

The use of the ENCePP Seal has been discontinued since February 2025. The ENCePP Seal fields are retained in the display mode for transparency but are no longer maintained.

No information provided.

Post Authorization Safety Study (PASS) to Investigate Relevant Safety Outcomes among Patients Treated with Benepali for Psoriasis within the British Association of Dermatologists Biologic Interventions Register (BADBIR)

Secondary tabs

Share this page